Immune response in COVID-19: what is next?

Qing Li(Soochow University), Ying Wang(Shanghai Jiao Tong University), Qiang Sun(Chinese Academy of Medical Sciences & Peking Union Medical College), Jasmin Knopf(Friedrich-Alexander-Universität Erlangen-Nürnberg), Martin Herrmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Liangyu Lin(Shanghai Jiao Tong University), Jingting Jiang(Soochow University), Changshun Shao(Soochow University), Peishan Li(Soochow University), Xiaozhou He(Soochow University), Fei Hua(Soochow University), Zubiao Niu(Chinese Academy of Medical Sciences & Peking Union Medical College), Chaobing Ma(Chinese Academy of Medical Sciences & Peking Union Medical College), Yichao Zhu(Chinese Academy of Medical Sciences & Peking Union Medical College), Giuseppe Ippolito(Ministero della Salute), Mauro Piacentini(University of Rome Tor Vergata), Jérôme Estaquier(Inserm), Sonia Melino(University of Rome Tor Vergata), Felix D. Weiss(University of Bonn), Emanuele Andreano(GlaxoSmithKline (Italy)), Eicke Latz(University of Bonn), Joachim L. Schultze(University of Bonn), Rino Rappuoli(GlaxoSmithKline (Italy)), Alberto Mantovani(Humanitas University), Tak W. Mak(University Health Network), Gerry Melino(University of Rome Tor Vergata), Yufang Shi(University of Rome Tor Vergata)
Cell Death and Differentiation
May 17, 2022
Cited by 136Open Access
Full Text

Abstract

The coronavirus disease 2019 (COVID-19) has been a global pandemic for more than 2 years and it still impacts our daily lifestyle and quality in unprecedented ways. A better understanding of immunity and its regulation in response to SARS-CoV-2 infection is urgently needed. Based on the current literature, we review here the various virus mutations and the evolving disease manifestations along with the alterations of immune responses with specific focuses on the innate immune response, neutrophil extracellular traps, humoral immunity, and cellular immunity. Different types of vaccines were compared and analyzed based on their unique properties to elicit specific immunity. Various therapeutic strategies such as antibody, anti-viral medications and inflammation control were discussed. We predict that with the available and continuously emerging new technologies, more powerful vaccines and administration schedules, more effective medications and better public health measures, the COVID-19 pandemic will be under control in the near future.


Related Papers

No related papers found

Powered by citation graph analysis